Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexes

Genes and Development

Volumn 11, Issue 23, 1997, Pages 3157-3167

  Liu, Fang ^a   Pouponnot, Celio ^a   Massagué, Joan ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Activin; BMP; Signal transduction; SMAD; TGF ; Transcriptional regulation; Tumor suppressors

Indexed keywords

ACTIVIN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE DELETION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0030690337     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.23.3157     Document Type: Article

References (59)

1. Baker, J. and R.M. Harland. 1996. A novel mesoderm inducer, mMadr-2, functions in the activin signal transduction pathway. Genes & Dev. 10: 1880-1889.
2. Barrett, M.T., M. Schutte, S.E. Kern, and B.J. Reid. 1996. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res. 56: 4351-4353.
3. Cárcamo, J., F.M.B. Weis, F. Ventura, R. Wieser, J.L. Wrana, L. Attisano, and J. Massagué. 1994. Type I receptors specify growth inhibitory and transcriptional responses to TGF-β and activin. Mol. Cell Biol. 14: 3810-3821.
4. Chen, X., M.J. Rubock, and M. Whitman. 1996. A transcriptional partner of MAD proteins in TGF-β signaling. Nature 383: 691-696.
5. Chen, X., E. Weisberg, V. Fridmacher, M. Watanabe, G. Naco, and M. Whitman. 1997. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389: 85-89.
6. Datto, M.B., Y. Yu, and X.-F. Wang. 1995. Functional analysis of the transforming growth factor β responsive elements in WAF1/Cip1/p21 promoter. J. Biol. Chem. 270: 28623-28628.
7. de Caestecker, M.P., P. Hemmati, S. Larisch-Bloch, R. Ajmera, A.B. Roberts, and R.J. Lechleider. 1997. Characterization of functional domains within Smad4/DPC4. J. Biol. Chem. 272: 13690-13696.
8. Derynck, R. and Y. Zhang. 1996. Intracellular signaling: The Mad way to do it. Curr. Biol. 6: 1226-1229.
9. Eppert, K., S.W. Scherer, H. Ozcelik, R. Pirone, P. Hoodless, H. Kim, L.-C. Tsui, B. Bapat, S. Gallinger, I.L. Andrulis, G.H. Thomsen, J.L. Wrana, and L. Attisano. 1996. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related pro3tein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552.
10. Goyette, M.C., K. Cho, C.L. Fasching, D.B. Levy, K.W. Kinzler, C. Paraskeva, B. Vogelstein, and E.J. Stanbridge. 1992. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol. 12: 1387-1395.
11. Graff, J.M., A. Bansal, and D.A. Melton. 1996. Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 85: 479-487.
12. Hahn, S.A., M. Schutte, A.T.M.S. Hoque, C.A. Moskaluk, L.T. da Costa, E. Rozenblum, C.L. Weinstein, A. Fischer, C.J. Yeo, R.H. Hruban, and S.E. Kern. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353.
13. Hannon, G.J. and D. Beach. 1994. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261.
14. Hata, A., R.S. Lo, D. Wotton, G. Lagna, and J. Massagué. 1997. Mutations increasing autoinhibition inactivate the tumour suppressors Smad2 and Smad4. Nature 388: 82-86.
15. Hayashi, H., S. Abdollah, Y. Qiu, J. Cai, Y.Y. Xu, B.W. Grinnell, M.A. Richardson, J.N. Topper, M.A. Gimbrone, J.L. Wrana, and D. Falb. 1997. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89: 1165-1173.
16. Hoodless, P.A., T. Haerry, S. Abdollah, M. Stapleton, M.B. O'Connor, L. Attisano, and J.L. Wrana. 1996. MADRI, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85: 489-500.
17. Huang, H.-C., L.C. Murtaugh, P.D. Vize, and M. Whitman. 1995. Identification of a potential regulator of early transcriptional responses to mesoderm inducers in the frog embryo. EMBO J. 14: 5965-5973.
18. Iavarone, A. and J. Massagué. 1997. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-in cells lacking the CDK inhibitor p15. Nature 387: 417-422.
19. Inagaki, Y., S. Truter, and F. Ramirez. 1994. TGF-β stimulates a2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J. Biol. Chem. 269: 14828-14834.
20. Keeton, M.R., S.A. Curriden, A.-J. van Zonneveld, and D. Loskutoff. 1991. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor β. J. Biol. Chem. 266: 23048-23052.
21. Kerr, L.D., N.E. Olashaw, and L.M. Matrisian. 1988. Transforming growth factor β1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA. J. Biol. Chem. 263: 16999-17005.
22. Kim, S.K., Y. Fan, V. Papadimitrakopoulou, G. Clayman, W.N Hittelman, W.K. Hong, R. Lotan, and L. Mao. 1996. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res. 56: 2519-2521.
23. Kim, J., K. Johnson, H.J. Chen, S. Carroll, and A. Laughon. 1997. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388: 304-308
24. Kretzschmar, M., F. Liu, A. Hata, J. Doody, and J. Massagué 1997a. The TGF-β mediator Smadl is directly phosphorylated and functionally activated by the BMP receptor kinase. Genes & Dev. 11: 984-995.
25. Kretzschmar, M., J. Doody, and J. Massagué. 1997b. Opposing BMP and EGF signaling pathways converge on the TGFβ family mediator Smad1. Nature 389: 618-622.
26. Lagna, G., A. Hata, A. Hemmati-Brivanlou, and J. Massagué. 1996. Partnership between DPC4 and SMAD proteins in TGFβ signaling pathways. Nature 383: 832-836.
27. Lechleider, R.J., M.P. de Caestecker, A. Dehejia, M.H. Polymeropoulos, and A.B. Roberts. 1996. Serine, phosphorylation, chromosomal localization and TGFβ signal transduction by human bsp-1. J. Biol. Chem. 271: 17617-17620.
28. Lillie, J.W. and M.R. Green. 1989. Transcription activation by the adenovirus E1A protein. Nature 338: 39-44.
29. Liu, F., A. Hata, J. Baker, J. Doody, J. Cárcamo, R. Harland, and J. Massagué. 1996. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381: 620-623.
30. Macias-Silva, M., S. Abdollah, P.A. Hoodless, R. Pirone, L. Attisano, and J.L. Wrana. 1996. MADR2 is a substrate of the TGFβ receptor and phosphorylation is required for nuclear accumulation and signaling. Cell 87: 1215-1224.
31. Massagué, J., A. Hata, and F. Liu. 1997. TGFβ signaling through the Smad pathway. Trends Cell Biol. 7: 187-192.
32. Nagatake, M., Y. Takagi, H. Osada, K. Uchida, T. Mitsudomi, S. Saji, K. Shimokata, T. Takahashi, and T. Takahashi, 1996. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res. 56: 2718-2720.
33. Nakao, A., E. Röijer, T. Imamura, S. Souchelnytskyi, G. Stenman, C.-H. Heldin, and P. ten Dijke. 1997. Identification of Smad2, a human Mad-related protein in the transforming growth factor-β signaling pathway. J. Biol. Chem. 272: 2896-2900.
34. Nakao, A., T. Imamura, S. Souchelnytskyi, M. Kawabata, A. Ishisaki, E. Oeda, K. Tamaki, J.-i. Hanai, C.-H. Heldin, K. Miyazono, and P. ten Dijke. 1997. TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4. EMBO J. 16: 5353-5362.
35. Newfeld, S.J., E.H. Chartoff, J.M. Graff, D.M. Melton, and W.M. Gelbart. 1996. Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGFresponsive cells. Development 122: 2099-2108.
36. Pietenpol, J.A., R.W. Stein, E. Moran, P. Yacuik, R. Schlegel, R.M. Lyons, R.M. Pittelkow, K. Münger, P.M. Howley, and H.L. Moses. 1990. TGF-β1 Inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming protein with pRB binding domains. Cell 61: 777-785.
37. Reynisdóttir, I., K. Polyak, A. lavarone, and J. Massagué. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arest in response to TGF-β. Genes & Dev. 9: 1831-1845.
38. Riggins, G.J., S. Thiagalingam, E. Rozenblum, C.L. Weinstein, S.E. Kern, S.R. Hamilton, J.K.V. Willson, S.D. Markowitz, K.W. Kinzler, and B. Vogelstein. 1996. Mad-related genes in the human. Nature Genet. 13: 347-349.
39. Rossi, P., G. Karsenty, A.B. Roberts, N.S. Roche, M.B. Sporn, and B. de Crombrugghe. 1988. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β. Cell 5: 405-414.
40. Sadowski, I. and M. Ptashne. 1989. A vector for expressing GAL4(1-147) fusion in mammalian cells. Nucleic Acid Res. 17: 7539.
41. Savage, C., P. Das, A. Finelli, S.R. Townsend, C.-Y. Sun, S.E. Baird, and R.W. Padgett. 1996. Caenorhabditis elegans genes sma-2, sma-3 and sma-4 define a conserved family of transforming growth factor β pathway components. Proc. Natl. Acad. Sci. 93: 790-794.
42. Schutte, M., R.H. Hruban, L. Hedrik, K.R. Cho, G.M. Nadasdy, C.L. Weinstein, G.S. Bova, W.B. Isaacs, P. Cairns, H. Nawroz, D. Sidransky, C.A. Casero, P.S. Meltzer, S.A. Hahn, and S.E. Kern. 1996. DPC4 gene in various tumor types. Cancer Res. 56: 2527-2530.
43. Sekelsky, J.J., S.J. Newfeld, L.A. Raftery, E.H. Chartoff, and W.M. Gelbart. 1995. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139: 1347-1358.
44. Shi, Y., A. Hata, R.S. Lo, J. Massagué, and N.P. Pavletich. 1997. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388: 87-93.
45. Thomsen, G. 1996. Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor. Development 122: 2359-2366.
46. Topper, J.N., J. Cai, Y. Qiu, K.R. Anderson, Y.Y. Xu, J.D. Deeds, R. Feeley, C.J. Gimeno, E.A. Woolf, O. Tayber, G.G. Mays, B.A. Sampson, F.J. Schoen, M.A. Gimbrone, and D. Falb. 1997. Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl. Acad. Sci. 94: 9314-9319.
47. Turner, D.L. and H. Weintraub. 1994. Expression of achaetescute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate. Genes & Dev. 8: 1434-1447.
48. Uchida, K., M. Nagatake, H. Osada, Y. Yatabe, M. Kondo, T. Mitsudomi, A. Masuda, T. Takahashi, and T. Takahashi. 1996. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res. 56: 5583-5585.
49. Watanabe, T.K., M. Suzuki, Y. Omori, H. Hishigaki, M. Horie, N. Kanemoto, T. Fujiwara, Y. Nakamura, and E. Takahashi. 1997. Cloning and characterization of a novel member of the human Mad gene family (MADH6). Genomics 42: 446-451.
50. Weis-Garcia, F. and J. Massagué. 1996. Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J. 15: 276-289.
51. Wiersdorff, V., T. Lecuit, S.M. Cohen, and M. Mlodzik. 1996. Mad acts downstream of Dpp receptors, revealing differential requirement for dpp signaling in initiation and propagation of morphogenesis in the Drosophila eye. Development 122: 2153-2162.
52. Wieser, R., J.L. Wrana, and J. Massagué. 1995. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14: 2199-2208.
53. Wrana, J.L. and L. Attisano. 1996. MAD-related proteins in TGFβ signaling. Trends Genet. 12: 493-496.
54. Wrana, J.L., L. Attisano, R. Wieser, F. Ventura, and J. Massagué. 1994. Mechanism of activation of the TGF-β receptor. Nature 370: 341-347.
55. Wu, R.-Y., Y. Zhang, X.-H. Feng, and R. Derynck. 1997. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/ DPC4. Mol. Cell Biol. 17: 2521-2528.
56. Yingling, J.M., P. Das, C. Savage, C. Zhang, R.W. Padgett, and X.-F. Wang. 1996. Mammalian Dwarfins are phosphorylated in response to TGF-β and are implicated in control of cell growth. Proc. Natl. Acad. Sci. 93: 8940-8944.
57. Zentella, A. and J. Massagué. 1992. TGF-β induces myoblast differentiation in the presence of mitogens. Proc. Natl. Acad. Sci. 89: 5176-5180.
58. Zhang, Y., X.-H. Feng, R.-Y. Wu, and R. Derynck. 1996. Receptor-associated Mad homologs synergize as effectors of the TGFβ response. Nature 383: 168-172.
59. Zhang, Y., T. Musci, and R. Derynck. 1997. The tumor suppressor Smad4/DPC4 as a central mediator of Smad function. Curr. Biol. 7: 270-276.